ReVivo Medical

ReVivo Medical, LLC is an early-stage medical device development company focused on implantable devices to improve treatments for back and neck pain – an $800 million market. Prototype implants have been made and laboratory tested to confirm mechanical properties, and early efficacy results indicate that ReVivo’s technology is performing equal to or better than the existing dynamic implants, and third-party physicians prefer their plate. They were awarded a $225,000 Phase I SBIR grant from the National Institutes of Health.